Efstathios Gotsis
Overview
Explore the profile of Efstathios Gotsis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
107
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ladis V, Berdousi H, Gotsis E, Kattamis A
Br J Haematol
. 2010 Oct;
151(5):504-8.
PMID: 20950401
Abnormal iron regulation in patients with thalassaemia intermedia may lead to iron overload even in the absence of transfusions. There are limited data on iron chelator use in patients with...
2.
Mavrogeni S, Gotsis E, Verganelakis D, Berdousis E, Dritsas A, Kolovou G, et al.
Int J Cardiovasc Imaging
. 2009 Aug;
25(8):777-83.
PMID: 19680779
In b-thalassemia, myocardial iron overload contributes to heart failure, despite chelation treatment. We hypothesized that myocardial T2*, an index of iron overload, influences patients' physical activity. We assessed a thalassemic...
3.
Mavrogeni S, Gotsis E, Ladis V, Berdousis E, Verganelakis D, Toulas P, et al.
Int J Cardiovasc Imaging
. 2008 Jun;
24(8):849-54.
PMID: 18581254
Introduction: b-Thalassemia major (TM) and thalassemia intermedia (TI) are forms of inherited hemoglobinopathies. Our aim was to evaluate a population of asymptomatic TM and TI patients using cardiovascular magnetic resonance...
4.
Farmaki K, Gotsis E, Tzoumari I, Berdoukas V
Eur J Haematol
. 2008 May;
81(2):157-9.
PMID: 18462251
In general, in women with transfusion-dependent thalassemia, during pregnancy, iron chelation therapy is ceased. We report a splenectomized patient, who was an excellent complier with chelation therapy, who before embarking...
5.
Giakoumis A, Berdoukas V, Gotsis E, Aessopos A
Cardiovasc Ultrasound
. 2007 Jul;
5:24.
PMID: 17629926
Background: Despite advances in survival in patients with thalassemia major (TM) the most common cause of death is cardiac disease. Regular cardiac follow-up is imperative in order to identify and...
6.
Aessopos A, Giakoumis A, Fragodimitri C, Karabatsos F, Hatziliami A, Yousef J, et al.
Eur J Haematol
. 2006 Oct;
78(1):58-65.
PMID: 17038018
Background And Objective: Heart iron load (cardiac Fe) can be indirectly quantified by cardiac magnetic resonance (CMR) T2*. CMR accessibility is limited, whereas echocardiography (Echo) is relatively inexpensive and readily...
7.
Farmaki K, Angelopoulos N, Anagnostopoulos G, Gotsis E, Rombopoulos G, Tolis G
Br J Haematol
. 2006 Jul;
134(4):438-44.
PMID: 16822284
Recently introduced chelation regimens that combine deferoxamine (DFO) and deferiprone have been shown to have greater efficacy in promoting iron excretion than either chelator alone and have been associated with...
8.
Platis O, Anagnostopoulos G, Farmaki K, Posantzis M, Gotsis E, Tolis G
Pediatr Endocrinol Rev
. 2006 Feb;
2 Suppl 2:279-81.
PMID: 16462711
Thalassaemic patients with haemocromatosis often present with metabolic disturbances such as diabetes mellitus. A group of adult thalassaemic patients who received intensive oral and subcutaneous chelation therapy (Defferiprone/Ferriprox and Desferioxamine/Desferal)...